Evidence map›Paper›PMID 39130341›Full record

ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2024

Successful Treatment of Severe Aplastic Anemia with Hematopoietic Stem Cell Transplantation in the Setting of Active Mucormycosis.

Suleimen Zhumatayev, Safiye Suna Celen, Manolya Kara, Ayse Adin Selcuk, Betül Bozkurt, Mustafa Kemal Demir, Koray Yalcın

Abstract read
In one paragraph

Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Suleimen ZhumatayevDepartment of Pediatric Hematology, Bahçeşehir University School of Medicine, Istanbul, Turkey.ORCID 0000-0002-4409-8180
Safiye Suna CelenDepartment of Pediatric Hematology, Bahçeşehir University School of Medicine, Istanbul, Turkey.ORCID 0000-0002-7930-2081
Manolya KaraDepartment of Pediatric Infectious Diseases, Yeditepe University School of Medicine, Istanbul, Turkey.ORCID 0000-0001-6234-7024
Ayse Adin SelcukDepartment of Otorhinolaringology, Bahçeşehir University School of Medicine, Istanbul, Turkey.ORCID 0000-0002-3267-4638
Betül BozkurtDepartment of Pediatric Hematology, Bahçeşehir University School of Medicine, Istanbul, Turkey.ORCID 0000-0003-1115-9538
Mustafa Kemal DemirDepartment of Radiology, Bahçeşehir University School of Medicine, Istanbul, Turkey.ORCID 0000-0002-7023-6153
Koray YalcınDepartment of Pediatric Hematology, Bahçeşehir University School of Medicine, Istanbul, Turkey.ORCID 0000-0003-3454-9870

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe aplastic anemia (SAA) is a life-threatening hematological disease characterized by the suppression of the bone marrow. Patients with SAA are predisposed to recurrent bacterial infections and invasive fungal infections (IFI) due to profound and persistent neutropenia. Mucorales are the second most common cause of IFI encountered in SAA. Here we present a pediatric case of SAA with active mucormycosis infection of the paranasal sinuses. In the first step, surgical debridement was performed and combined antifungal therapy (liposomal amphotericin B, posaconazole, caspofungin) was started. Due to severe neutropenia, daily granulocyte transfusion was added to therapy. Hyperbaric oxygen therapy was applied for wound healing. After all this the patient went under flap surgery. One week after the successful flap procedure, HSCT was performed and he had no complications related to HSCT. The patient was followed in the outpatient clinic for 6 months with posaconazole. Now, he is out of drugs and followed without problems for 15 months after HSCT. Our case confirms that urgent HSCT with multiple therapies (surgical debridement, granulocyte support, combined antifungal therapy, hyperbaric O2) is crucial for saving life in SAA patients with active mucormycosis.

Indexed as

Aplastic anemiaHematopoietic stem cell transplantationMucormycosis

Identifiers

PMID39130341
PMCPMC11306456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.